Company profile
Brainstorm Cell Therapeutics Inc. Insider Trading
BCLIEvery SEC Form 4 insider trading filing for Brainstorm Cell Therapeutics Inc. (BCLI) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- OTC
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001137883
- Filings
- 52
- Insiders
- 13
- Last filing
- 2026-07-24
Activity summary
No insider transactions in the last 30 days. The most recent was on July 24, 2026, when Peter Joe Pitts reported 900,000 shares (Award). 52 filings from 13 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Brainstorm Cell Therapeutics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $756K.
90 day insight
Over the last 90 days, Brainstorm Cell Therapeutics Inc. insiders filed 2 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Peter Joe Pitts with 1 transaction totaling $0.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 50 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 22, 2024 | Chaim Lebovits | BCLI | Purchase | 25,000 | $0.64 | $16K |
| May 21, 2024 | Chaim Lebovits | BCLI | Purchase | 25,000 | $0.58 | $14K |
| May 7, 2024 | Chaim Lebovits | BCLI | Purchase | 66,300 | $0.37 | $25K |
| May 6, 2024 | Chaim Lebovits | BCLI | Purchase | 135,000 | $0.38 | $51K |
| Apr 18, 2024 | Chaim Lebovits | BCLI | Purchase | 115,072 | $0.53 | $60K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=BCLI" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By open-market value traded.